csestocks
Quimbaya Gold (CSE:QIM,OTCQB:QIMGF)has begun exploration work and is now gearing up for a 3,000 meter drilling program at its newly acquired property in Segovia, Colombia, according to Alexandre Boivin, the company’s president and CEO. The 2,000 hectare mining property, prospective for gold and silver, is near Aris Mining’s (TSX:ARIS,NYSEAMERICAN:ARMN) Segovia operations in Antioquia, Colombia. The region is well known for its high-grade gold veins, making the acquisition highly significant for Quimbaya’s growth trajectory. “The goal in mining and exploration, like a company like Quimbaya, is ...
Investing News Network
Sona Nanotech (CSE:SONA,OTCQB:SNANF) announced results from biomarker analysis of a recent pre-clinical melanoma study, reporting that its Targeted Hyperthermia Therapy (THT) can not only shrink existing tumors, but under specific circumstances can also trigger an immune system to prevent new tumors from forming. The pre-clinical study, which was conducted at Dalhousie University, revealed that Sona's THT stimulates the immune system to target and eliminate distant tumors when combined with the immunotherapeutic drug IL-2. In a Wednesday (June 26) press release, Dr. Carman Giacomantonio, Sona'...
Investing News Network
The copper market's current state presents both a challenge and an opportunity for explorers like Prismo Metals (CSE:PRIZ,OTCQB:PMOMF,FWB:7KU), Steve Robertson, the company’s new president, told the Investing News Network. A forecast supply deficit looms on the horizon and is expected to take full effect by 2025, prompting a sense of urgency among copper producers and explorers alike. "For quite some time now ... there's been a deficit, this forecast for 2025," Robertson said, pointing to a critical market juncture. This imbalance is being influenced by the complex nature of copper mining, whi...
Investing News Network
Sona Nanotech (CSE:SONA,OTCQB:SNANF) is ramping up clinical trials for its targeted hyperthermia therapy (THT) for cancer. CEO David Regan said the company is looking forward to taking THT into in-human studies after interim results from its efficacy study on animals showed statistically significantly superior results. “We went into this study with a simple hypothesis that our THT for cancer would shrink cells and … tumors from the inside out … But we found something more interesting along the way,” he said. “We've seen in this study it’s not just that the treated tumor shrinks, but that you'r...
Investing News Network
Lancaster Resources (CSE:LCR,OTCQB:LANRF,FWB:6UF0) is gearing up to drill an exploration well at its Alkali Flat lithium brine project in New Mexico following the receipt of a technically complete letter from the New Mining and Minerals Division pertaining to its permit application. “Hopefully we can get started within the next 30 to 60 days,” said CEO Penny White. “Basically we'll be doing our exploratory well, which is really just a drill that will go down about 700 meters. And what we'll be able to do is explore that to really interesting targets that we've delineated through all of our exp...
Investing News Network
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら